Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anfibotide in STEMI Patients Undergoing PCI (Phase IIb)
CTR20150479Phase 2Completed
- Sponsor
- Hefei Zhaofeng Keda Pharmaceutical
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anfibatide in myocardial infarction (MI), sponsored by Hefei Zhaofeng Keda Pharmaceutical. Started Sep 2015; status: completed.
02
Drugs
anfibatide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on CTR20150479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150479.